威高股份中期报告2024

SUMMARY Forthesixmonthsended30June2024(the“Period”),theunauditedrevenueofShandongWeigaoGroupMedicalPolymerCompanyLimited(the“Company”)anditssubsidiaries(the“Group”)wasapproximatelyRMB6,635,688,000(sameperiodin2023:approximatelyRMB6,897,700,000),representingadecreaseofapproximately3.8%ascomparedwiththesameperiodlastyear,theunauditednetprofitattributabletotheownersoftheCompanywasapproximatelyRMB1,107,549,000(sameperiodin2023:approximatelyRMB1,197,767,000),representingadecreaseofapproximately7.5%ascomparedwiththesameperiodlastyear. Theboardofdirectors(the“Board”)proposedthedistributionofaninterimdividendforthesixmonthsended30June2024ofRMB0.0919pershare(sameperiodin2023:RMB0.0734pershare).TheproposalissubjecttotheapprovalofshareholdersoftheCompany(the“Shareholders”)attheforthcomingextraordinarygeneralmeeting. 概要 山东威高集团医用高分子制品股份有限公司（“本公司”）及其附属公司（“本集团”）截至二零二四年六月三十日止六个月（“期间”），未经审核之收入约人民币6,635,688,000元（二零二三年 同期：约人民币6,897,700,000元），较去年同期下跌约3.8%，未经审核之本公司拥有人应占纯利约人民币 同期下跌约1,197,767,000元），较去年 1约,1人07民,5币49,000元（二零二三年同期： 7.5%。 董事会（“董事会”）建议派发截至二零二四年六月三十日止六个月之中期 股息每股人民币0.0919元（二零二三年同期：每股人民币0.0734元）。该建 议须经本公司股东（“股东”）在即将举 行的股东特别大会上批准后，方可作实。 UNAUDITEDCONDENSEDCONSOLIDATEDINTERIMRESULTS TheBoardispleasedtoannouncetheunauditedcondensedconsolidatedinterimresultsoftheGroupforthesixmonthsended30June2024,togetherwiththeunauditedcomparativefiguresforthesameperiodin2023asfollows: UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME 未经审核简明综合中期业绩 董事会欣然宣布本集团于截至二零二四年六月三十日止六个月未经审核简明综合中期业绩，连同二零二三年同期未经审核比较数字如下： 未经审核简明综合全面收益表 Revenue收入 Costofsales销售成本 Otherincome,gainsandlosses其他收入、收益及亏损 Grossprofit毛利 3 6,635,688 6,897,700 (3,259,245) (3,354,221) 3,376,443 3,543,479 191,376 173,617 (7,490) (11,864) (1,264,556) (1,321,107) (539,773) (537,778) (301,613) (294,558) 4 (128,776) (138,174) 47,633 53,598 (6,865) 1,126 5 1,366,379 1,468,339 6 (212,809) (225,267) 1,153,570 1,243,072 Impairmentlossesunderexpectedcredit预期信贷亏损模型下之减值 Unaudited 未经审核 30June Forthesixmonthsended 截至六月三十日止六个月 二零二四年二零二三年 20242023 附注人民币千元人民币千元 NotesRMB’000RMB’000 lossmodel亏损 Administrationexpenses行政开支 Sellingexpenses销售开支 Financecosts融资成本 Shareofresultsofassociates应占联营公司业绩 Researchanddevelopmentexpenses研发开支 Shareofresultsofjointventures应占合营企业业绩 Incometaxexpense所得税开支 Profitbeforetaxation除税前溢利 ProfitforthePeriod期间内溢利 Othercomprehensiveincome其他全面收入 Unaudited 未经审核 30June Forthesixmonthsended 截至六月三十日止六个月 二零二四年二零二三年 20242023 附注人民币千元人民币千元 NotesRMB’000RMB’000 Exchangedifferenceontranslationofforeignoperations TotalcomprehensiveincomeforthePeriod 换算海外业务产生汇兑差额 期间内全面收入总额 17,077 1,170,647 154,061 1,397,133 OwnersoftheCompany本公司拥有人 1,107,549 1,197,767 46,021 45,305 1,153,570 1,243,072 ProfitforthePeriodattributableto:期间内溢利下列各项应占： Non-controllinginterests非控股权益 Totalcomprehensiveincomeattributableto: 全面收入总额下列各项应占： Non-controllinginterests非控股权益 1,125,269 45,3781,170,647 1,335,382 61,751 1,397,133 Earningspershare(basic)每股盈利（基本）8 Earningspershare(diluted)每股盈利（摊薄）8 OwnersoftheCompany本公司拥有人 RMB 人民币 0.25元 0.24元 RMB 人民币 0.27元 0.26元 UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTOFFINANCIALPOSITION Non-currentassets非流动资产 未经审核简明综合财务状况表 附注 Asat30June 2024 二零二��年 三十六日月 RMB’000 人民币千元Unaudited未经审核 Asat31December 2023 二零二三年�三十一二日月RMB’000 人民币千元 Audited 经审核 6,586,600 6,512,423 486,039 494,308 132,805 135,611 3,749,130 3,727,790 238,443 328,302 1,399,503 1,507,337 1,509,014 1,461,381 342,642 349,318 82,960 86,910 187,222 207,102 8,202 15,302 220,625 147,191 58,379 62,965 15,001,564 15,035,940 Note Right-of-useassets使用权资产 Investmentproperties投资物业 Property,plantandequipment物业、厂房及设备9 Depositspaidforacquiringproperty,plantandequipment 就设收备购之物已业、付厂按房金及 Goodwill商誉 Interestsinassociates于联营公司的权益 Deferredtaxassets递延税项资产 Interestsinjointventures于合营企业的权益 Intangibleassets无形资产 Financialassetsatfairvaluethroughprofitorloss 按计公量平之值金计融入资损产益 Loanreceivables应收贷款 Financeleasereceivables应收融资租赁款项 Prepayments预付款项11 Inventories存货 Loanreceivables应收贷款 附注 Currentassets流动资产 Tradeandotherreceivables应其收他贸应易收账款项及 Note Asat31December � 2023 三十二一月日 二零二三年 人民币千元 RMB’000 经审核 10 2,310,775 2,495,352 570,638 642,476 11 8,033,761 7,365,212 2,162 371 336,760 344,211 33,689 42,963 12 725,505 754,975 13 7,527,635 6,988,731 19,540,925 18,634,291 14 4,741,221 4,319,784 385,479 424,492 647,372 2,546,750 – 7,653 141,907 239,964 9,789 7,369 26,487 26,587 7,376 9,442 5,959,631 7,582,041 13,581,294 11,052,250 28,582,858 26,088,190 Audited 债务工具 Financialassetsatfairvaluethroughprofitorloss Debtinstrumentsatfairvaluethroughothercomprehensiveincome 按计公量平之值金计融入资损产益按公平值计计入量其之他 Pledged/restrictedbankdeposits已存抵款押╱受限制银行 Financeleasereceivables应收融资租赁款项 Bankbalancesandcash银行结余及现金 Contractliabilities合约负债 Currentliabilities流动负债 Borrowings借款 Tradeandotherpayables应其付他贸应易付账款项及 Financialliabilitiesatfairvaluethroughprofitorloss 按计公量平之值金计融入负损债益 二零二��年 Asat30June 2024 三十六日月 Unaudited 人民币千元 RMB’000 未经审核 Deferredincome递延收入 Taxationpayable应付税项 Provisions拨备 Leaseliabilities租赁负债 Netcurrentassets流动资产净额 Totalassetslesscurrentliabilities总资产减流动负债 Sh